Biologics, Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
46
NCT06534060
MB-105 in Patients With CD5 Positive T-cell Lymphoma
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 15, 2025
Completion: Dec 31, 2029
Loading map...